Top Tweets for #BotBal
ICYMI: Prof. Alexander Eggermont shared how France’s AAC program gives patients access to #BOTBAL—“a unique combo with efficacy across multiple tumor types.”
Watch his full remarks on global impact ▶️ https://t.co/KkvIE4uAng
#Immunotherapy #CancerCare #GlobalAccess
Today, 4 PM ET: #Agenus Stakeholder Briefing on #BOTBAL global momentum + post-#ESMO2025 insights.
With Dr. Michael Gordon & Prof. Alexander Eggermont.
🎥 Watch live: https://t.co/bNycRwBg46
#ImmunoOncology
Emerging survival plateaus with BOT/BAL across advanced solid tumors.
Presented by Dr. Michael Gordon at #ESMO2025 from a 400+ patient Phase 1b study of refractory cancers.
See the full presentation → https://t.co/RrXNv940FO
#BOTBAL #ImmunoOncology
New #ESMO2025 data: BOT/BAL shows 39% of patients alive at 2 years across multiple refractory tumors, including those who failed prior IO. Durable hope for patients left behind by first-gen immunotherapy.
Read the release: https://t.co/OLXJ6Yn4hn
#ImmunoOncology #BOTBAL
Join us Oct 21, 4PM ET for the next #Agenus Stakeholder Briefing—moderated by Dr. Garo Armen.
Hear from industry leaders report post #ESMO2025 BOT/BAL data and learn about expanding access.
🎥 Watch live → https://t.co/bNycRwAIey
#BOTBAL #ImmunoOncology
Missed the Agenus Stakeholder Briefing?
Catch the highlights in 4 minutes:
✔️ CRC crisis & urgent patient needs
✔️ Our bold vision for IO
✔️ BOT/BAL & Phase 3 BATTMAN
✔️ Partnership momentum
Watch below:
#ImmunoOncology #CRC #Biotech #BOTBAL #Agenus
France grants reimbursed early access to BOT/BAL for patients with metastatic MSS colorectal cancer under its Accès Compassionnel (AAC) program.
Read More: https://t.co/IYzQBvZEJ5
#ColorectalCancer #Immunotherapy #BOTBAL #France #AAC #Oncology
📢 NEW LINK: Don’t miss our Virtual Stakeholder Briefing on Aug 27 @ 4PM ET!
https://t.co/bNycRwAIey
We'll cover our progress, BOT/BAL data, BATTMAN trial preview + more.
#ImmunoOncology #BOTBAL #Biotech $AGEN
Zynext Ventures invests in @Agenus_Bio to accelerate their groundbreaking immunotherapy BOT/BAL.
@ZydusUniverse #ZynextVentures #Agenus #BiotechInvestment #CancerResearch #HealthcareInnovation #VentureCapital #immunooncology #Cancer #Oncology #Biotech #ASCO25 #ESMO #BOTBAL
To our Emeryville & Berkeley teams: you embody integrity and excellence, you now anchor global biotech trade! #BOTBAL #biotech #immunotherapy #USIndia #manufacturing #globalhealth
TCR dynamics after first dose BOTBAL are predictive for response - @GJRas
https://t.co/zcU1CbNRcf
#ASCO25 #BOTBAL #Cancer #FightAgainstCancer #Gastroenterology #GastrointestinalOncology #MedEd #MedX #GlobalFightAgainstCancer #OncoDaily #Oncology
🧐 Can you predict who’s responding to #BOTBAL and who isn’t? Discover it next week at #ASCO25!
🙋♂️ See you on:
Saturday 31st of May, 09:00AM to 12:00PM #CRC poster session, Hall A
Poster Bd 196 - Abstract No 3527
@UZLeuven @KU_Leuven @OmniscopeAI @Agenus_Bio @ASCO
🚨Highlights from #ASCOGI2025! Dr @GJRas unveils key advances in colorectal cancer. From immunotherapy breakthroughs to predictive biomarkers and preventive strategies, catch all the latest insights.
I ask Agenus to consider Armenia as the first country to register the BOT/BAL combination: Gevorg Tamamyan @GevTamamyan @Agenus_Bio
https://t.co/ZmXeSORwfn
#oncology #cancer #oncodaily #colorectalcancer #botbal #agenus
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day @ODayMD @Agenus_Bio
https://t.co/q1FRqDbhxk
#agenus #botensilimab #balstilimab #colorectalcancer #botbal #StevenODay #cancer #oncology #oncodaily
1/2
🪺 #NEST is true pioneering work by both @pashtoonkasi and @Agenus, unlocking #MSS #CRC with next generation #IO (#BOTBAL) in the #neoadjuvant setting.
📌 Even if patient numbers are still low atm, a true paradigm shift is waiting for us.
#ESMOGI24 @myESMO @oncodaily
@HPolymenis @Aiims1742 @KReissMD @PeterHoseinMD & others have shown that not all immunotherapies are alike.
PD1⛔️➕PARP⛔️ very different🆚CTLA4⛔️combinations.
Ongoing #BOTBAL studies are also evaluating if the BAL is necessary and what dose of BOT. T300➕D single dose continues to intrigues me. #GI23
@RenoHemonc @OncLive @ASCO @MayoCancerCare @OncoAlert @NRGonc @TGeorgeMD @RenoHemonc your wish is my command. 🧞
My investigator initiated trial got IRB approved this week! @ASCO #GI23
Here’s us building on the exciting data on #immunotherapy (with #BOTBAL) in the neoadjuvant space for #colorectalcancer.
#CRCSM #ctDNA🩸🧬
https://t.co/lIBkAeoHR2
Imitation is the sincerest form of flattery.
Here’s us building on the exciting data on #immunotherapy (with BOT/BAL) in the neoadjuvant space for #colorectalcancer.
NEST-1 is 1st of several efforts following NICHE-1.
#CRCSM #ctDNA🩸🧬
Link: https://t.co/lIBkAeoHR2
Thoughts?
#GI23 As @aparna1024 often refers to the “subsets of subsets”, we may need to have separate arms in #ClinicalTrials for patients with #colorectalcancer who have:
No Active Liver Metastases
🆚
Active Liver Metastases
💡❓Separate approaches. @sepideh_gholami #BOTBAL @OncoAlert
#ClinicalTrials
“Highlighting novel agents & promising data.
The #BotBal regimen showing a survival benefit in someone with no “active” liver metastases.
This is striking & similar trends with other IO➕💊 combinations. Good to see options in MSS.”
@pashtoonkasi @ASCO #GI23
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
240.3M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
109.8M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.5M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.7M followers
KATY PERRY
@katyperry
87.3M followers
Taylor Swift
@taylorswift13
81.1M followers
Lady Gaga
@ladygaga
72.6M followers
Kim Kardashian
@kimkardashian
69.6M followers
Virat Kohli
@imvkohli
69.3M followers
YouTube
@youtube
68.6M followers
Bill Gates
@billgates
63.6M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
61.9M followers
CNN
@cnn
61.9M followers
X
@x
60.9M followers
Selena Gomez
@selenagomez
60.4M followers